A RSK kinase inhibitor reporting its selectivity in vivo

Nature Chemical Biology

Volumn 3, Issue 3, 2007, Pages 138-139

  Frödin, Morten ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; BI D1870; PHENYLALANYLMETHIONYLLYSYLPROPARGYLAMINE; PROTEIN KINASE INHIBITOR; RIBOSOMAL S6 KINASE INHIBITOR; S6 KINASE; SL 0101; UNCLASSIFIED DRUG;

CELL DIVISION; CELL GROWTH; CELL SPECIFICITY; CELL SURVIVAL; DRUG DESIGN; DRUG SELECTIVITY; DRUG TARGETING; HUMAN; IN VIVO STUDY; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN STRUCTURE; SHORT SURVEY;

EID: 33847062105     PISSN: 15524450     EISSN: 15524469     Source Type: Journal    
DOI: 10.1038/nchembio0307-138     Document Type: Short Survey

References (7)

1. Cohen, M.S., Hadjivassiliou, H. & Taunton, J. Nat. Chem. Biol. 3, 156-160 (2007).
2. Cohen, M.S., Zhang, C., Shokat, K.M. & Taunton, J. Science 308, 1318-1321 (2005).
3. Hauge, C. & Frodin, M. J. Cell Sci. 119, 3021-3023 (2006).
4. Rostovtsev, V.V., Green, L.G., Fokin, V.V. & Sharpless, K.B. Angew. Chem. Int. Ed Engl. 41, 2596-2599 (2002).
5. Davies, S.P., Reddy, H., Caivano, M. & Cohen, P. Biochem. J. 351, 95-105 (2000).
6. Sapkota, G.P. et al. Biochem. J. 401, 29-38 (2007).
7. Smith, J.A. et al. Cancer Res. 65, 1027-1034 (2005).